Rashidul HAQUE; Sultana RAJIA. AMP-kinase is the Main Target of Metformin in Regulating Type 2 Diabetes. Research Highlights in Disease and Health Research Vol. 2, [S. l.], p. 83–95, 2023. DOI: 10.9734/bpi/rhdhr/v2/9366F. Disponível em: https://stm.bookpi.org/RHDHR-V2/article/view/9617. Acesso em: 4 jun. 2026.